Showing results (11-20 of 163) with videos related to
Sort By:
Pageof 17
Haematologica|March 25, 2014
The clinical significance of patients' sex in chronic lymphocytic leukemiaDaniel Catovsky, Rachel Wade, Monica ElseBest Practice & Research. Clinical Haematology|November 29, 2015
Long-term follow-up after purine analogue therapy in hairy cell leukaemiaMonica Else, Claire E Dearden, Daniel CatovskyMedical Oncology (Northwood, London, England)|August 16, 2002
Alemtuzumab in T-cell malignanciesClaire E Dearden, Estella Matutes, Daniel CatovskyLeukemia & Lymphoma|May 24, 2011
Long-term results for pentostatin and cladribine treatment of hairy cell leukemiaClaire E Dearden, Monica Else, Daniel CatovskyBritish Journal of Haematology|October 13, 2015
The long-term outcome of patients in the LRF CLL4 trial: the effect of salvage treatment and biological markers in those surviving 10 yearsMonica Else, Rachel Wade, David Oscier, et al.British Journal of Haematology|February 24, 2005
Pregnancy improves neutropenia in T-cell large granular lymphocyte leukaemiaNnenna Osuji, Estella Matutes, Claire Dearden, et al.Best Practice & Research. Clinical Haematology|July 13, 2010
Diagnostic issues in chronic lymphocytic leukaemia (CLL)Estella Matutes, Ayoma Attygalle, Andrew Wotherspoon, et al.Current Opinion in Hematology|December 18, 2004
Monitoring minimal residual disease in BCR-ABL-positive chronic myeloid leukemia in the imatinib eraJohn GoldmanLeukemia Research|April 4, 2006
Relationship between ARLTS1 polymorphisms and risk of chronic lymphocytic leukemiaGabrielle S Sellick, Daniel Catovsky, Richard S HoulstonLeukemia Research|December 21, 2004
Lessons from a case of T-cell large granular lymphocytic leukaemia suggesting that immunomodulatory therapy is more effective than intensive treatmentNnenna Osuji, Estella Matutes, Andrew Wotherspoon, et al.Pageof 17